文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛消化、代谢与肾脏急症

溺水相关肺炎的微生物学特征:系统评价与Meta分析

Microbiological features of drowning-associated pneumonia: a systematic review and meta-analysis.
PubMed 文献 · Ann Intensive Care · 2024-04-20
一句话结论溺水相关肺炎的合并患病率为39%,以革兰阴性菌(尤其淡水溺水后的气单胞菌属)为主;约30%分离菌对阿莫西林-克拉维酸耐药,经验性覆盖需考虑革兰阴性菌。

该系统评价与Meta分析纳入2000年1月至2023年7月发表的6项回顾性队列研究、共688例溺水患者,评估溺水相关肺炎(DAP)的合并患病率、病原微生物分布及对预后的影响。DAP合并患病率为39%(95%CI 29-48),淡水溺水为44%(95%CI 36-52),海水溺水为42%(95%CI 32-53);DAP对死亡率无显著影响(合并OR 1.43,95%CI 0.56-3.67),但该估计仅基于2项研究。呼吸道标本分离171株微生物,革兰阴性菌占57%(98/171),以气单胞菌属为主(20/171,12%);革兰阳性菌占22%(38/171),以金黄色葡萄球菌为主(21/171,12%)。气单胞菌属仅见于淡水溺水(19/106,18%),海水溺水未见(0%)(p=0.001)。作者认为经验性抗感染治疗应考虑覆盖革兰阴性菌,阿莫西林-克拉维酸在约三分之一病例中可能不足。

要点

  • 溺水相关肺炎合并患病率为39%(95%CI 29-48),淡水溺水44%(36-52)与海水溺水42%(32-53)相近。
  • 呼吸道标本以革兰阴性菌为主(98/171,57%),气单胞菌属占12%(20/171);革兰阳性菌占22%(38/171),金黄色葡萄球菌占12%(21/171)。
  • 气单胞菌属仅分离自淡水溺水(19/106,18%),海水溺水为0%(p=0.001),是唯一受水盐度显著影响的菌属。
  • 近30%分离菌对阿莫西林-克拉维酸耐药,而该药是DAP最常用的经验性处方药物之一。
  • DAP对死亡率无显著影响(合并OR 1.43,95%CI 0.56-3.67),但该估计仅基于2项研究,作者认为其预后影响仍不明确。

适用人群与场景

  • 溺水患者,研究来自欧洲(法国3项、荷兰1项)、美国(1项)和法属西印度群岛(1项),共688例。
  • 纳入标准为报告溺水相关肺炎发生情况和相关微生物的研究。

研究设计与关键结果

  • 研究设计:系统评价与Meta分析,检索2000年1月至2023年7月发表的研究;初筛309篇文献,最终纳入6项回顾性队列研究,共688例患者,单项研究样本量37至270例。
  • 研究地点:欧洲5项(法国3项、荷兰1项)、美国1项、法属西印度群岛1项;死亡率范围18%至81%。
  • DAP合并患病率为39%(95%CI 29-48);淡水溺水后合并患病率为44%(95%CI 36-52),海水溺水后为42%(95%CI 32-53)。
  • DAP对死亡率的影响无统计学显著性:合并OR为1.43(95%CI 0.56-3.67),但该估计仅基于2项研究。
  • 呼吸道标本共分离171株微生物:革兰阴性菌98/171(57%),以气单胞菌属为主(20/171,12%);革兰阳性菌38/171(22%),以金黄色葡萄球菌为主(21/171,12%)。
  • 水盐度对微生物分布影响有限,但气单胞菌属仅见于淡水溺水(19/106,18%),海水溺水为0%,差异有统计学意义(p=0.001)。
  • 无研究报告多重耐药菌;近30%分离微生物对阿莫西林-克拉维酸耐药,而该药是DAP最常用的经验性处方药物。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入的研究均为回顾性队列研究。
  • 局限:原文未报告局限性;但DAP对死亡率影响的合并OR仅基于2项研究,作者指出DAP对患者结局的影响仍不明确。

对床旁实践的改变

  • 作者认为经验性抗感染治疗应考虑覆盖革兰阴性菌,尤其气单胞菌属,因其仅见于淡水溺水。
  • 作者指出阿莫西林-克拉维酸在约三分之一DAP病例中可能不足。
  • 溺水相关肺炎对患者结局的影响仍不明确。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Drowning-associated pneumonia (DAP) is frequent in drowned patients, and possibly increases mortality. A better understanding of the microorganisms causing DAP could improve the adequacy of empirical antimicrobial therapy. We aimed to describe the pooled prevalence of DAP, the microorganisms involved, and the impact of DAP on drowned patients.

METHODS: Systematic review and meta-analysis of studies published between 01/2000 and 07/2023 reporting on DAP occurrence and microorganisms involved.

RESULTS: Of 309 unique articles screened, 6 were included, involving 688 patients. All were retrospective cohort studies, with a number of patients ranging from 37 to 270. Studies were conducted in Europe (France N = 3 and Netherland N = 1), United States of America (N = 1) and French West Indies (N = 1). Mortality ranged between 18 to 81%. The pooled prevalence of DAP was 39% (95%CI 29-48), similarly following freshwater (pooled prevalence 44%, 95%CI 36-52) or seawater drowning (pooled prevalence 42%, 95%CI 32-53). DAP did not significantly impact mortality (pooled odds ratio 1.43, 95%CI 0.56-3.67) but this estimation was based on two studies only. Respiratory samplings isolated 171 microorganisms, mostly Gram negative (98/171, 57%) and mainly Aeromonas sp. (20/171, 12%). Gram positive microorganisms represented 38/171 (22%) isolates, mainly Staphylococcus aureus (21/171, 12%). Water salinity levels had a limited impact on the distribution of microorganisms, except for Aeromonas sp. who were exclusively found following freshwater drowning (19/106, 18%) and never following seawater drowning (0%) (p = 0.001). No studies reported multidrug-resistant organisms but nearly 30% of the isolated microorganisms were resistant to amoxicillin-clavulanate, the drug that was the most commonly prescribed empirically for DAP.

CONCLUSIONS: DAP are commonly caused by Gram-negative bacteria, especially Aeromonas sp. which is exclusively isolated following freshwater drowning. Empirical antimicrobial therapy should consider covering them, noting than amoxicillin-clavulanate may be inadequate in about one-third of the cases. The impact of DAP on patients' outcome is still unclear.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Cousin VL, Pittet LF. Microbiological features of drowning-associated pneumonia: a systematic review and meta-analysis. Ann Intensive Care. 2024. PMID: 38641650. doi:10.1186/s13613-024-01287-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。